Overview (10 Jul 2020)
CADILA HEALTHCARE LTD.
CADILAHC
INE010B01027

Pharmaceuticals
Result was last declared on 19 Jun 2020
0.35

Prev. Close
Previous Close
356.05
Current Close
356.4
Current High
360.55
Current Low
354.5
52 Week High
383.6
52 Week Low
206.5
Resistance 1
359.80
Resistance 2
363.20
Support 1
353.75
Support 2
347.70
Std Deviation
3.79%
DMA 200
285.22
DMA 50
349.63
DMA 20
362.04
Fundamentals and Ratios
Trailing EPS
13.8
Forwad EPS
19.91
Trailing P/E
25.83
Forward P/E
17.9
PEG Ratio
0.4045
Mkt. Cap (Cr)
Market Cap (Cr)
36482.4
Total Debt(Cr)
Tot. Debt(Cr)
9025.70
Reserve (Cr)
10273.30
Book Value
101.36
P/BV Ratio
3.52
ROCE(%)
10.00
ROE
15.00

 

Financial Result - Standalone
TypeMar-20Dec-19Sep-19Jun-19Mar-19FY19-20
Revenue1812.21848.61682.71343.81667.86347.4
Other Income400.2038.80408.0027.0046.10849.40
Total Income2212.401887.402090.701370.801713.907196.80
Interest62.6035.3068.3026.3025.40233.90
Expenditure-1467.50-1565.60-1377.70-1277.00-1375.50-5587.10
PBDT0.000.000.000.000.000.00
Depreciation-112.30-97.50-92.40-90.00-88.40-428.90
PBT692.90321.80713.0093.80338.401557.70
Tax-86.40-40.20-85.10-15.10-76.30-204.10
Equity0.000.000.000.000.000.00
OPM38.2417.4142.376.8419.7422.00
Net Profit619.3281.6627.978.7262.11412.9
NPM34.1715.2337.325.7415.2920
EPS6.052.756.130.772.5613.8
Financial Result - Consolidated
TypeMar-20Dec-19Sep-19Jun-19Mar-19FY19-20
Revenue3752.13638.13366.63496.33732.814253.1
Other Income44.3020.1026.9022.6038.40113.90
Total Income3796.403658.203393.503518.903771.2014367.00
Interest82.5080.5089.7089.1077.30341.80
Expenditure-3221.90-3199.50-3003.00-3125.00-3165.30-12508.00
PBDT0.000.000.000.000.000.00
Depreciation-178.50-174.10-172.30-171.60-155.60-696.50
PBT522.00457.10122.40393.90605.901495.40
Tax-108.50-92.70-39.50-79.10-126.70-319.80
Equity0.000.000.000.000.000.00
OPM13.7512.503.6111.1916.0710.41
Net Profit413.7371.494325.3481.71204.4
NPM10.910.152.779.2412.778.38
EPS3.833.651.052.974.4911.49
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2020Interim Divvidend3.50Interim Dividend - Rs. - 3.500023 Mar 2020
2019Final Dividend3.50Final Dividend - Rs. - 3.500025 Jul 2019
2018Final Dividend3.50Dividend - Rs. - 3.500031 Jul 2018
2017Interim Divvidend3.20Interim Dividend - Rs. - 3.200016 Mar 2017
2016Interim Divvidend3.20Interim Dividend - Rs. - 3.200017 Mar 2016
2015Final Dividend12.00Dividend - Rs. - 12.000030 Jul 2015
2014Final Dividend9.00Dividend - Rs. - 9.000017 Jul 2014
2014Interim Divvidend7.50Interim Dividend - Rs. - 7.500011 Jun 2013
2012Final Dividend7.50Dividend - Rs. - 7.500026 Jul 2012
2011Final Dividend6.25Dividend - Rs. - 6.250007 Jul 2011
2010Final Dividend5.00Dividend - Rs. - 5.000015 Jul 2010
2009Final Dividend4.50Dividend - Rs. - 4.500016 Jul 2009
2008Final Dividend4.50Dividend - Rs. - 4.500010 Jul 2008
Bonus
YearRatioRemarkEx Date
20101:2Bonus issue 1:205 Apr 2010
Split
YearRatioRemarkEx Date
2015Rs.5/- to Rs.1/-Stock Split From Rs.5/- to Rs.1/-06 Oct 2015
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
AARTIDRUGS
1359.95
23.4
ABBOTINDIA
15512.6
55.59
AJANTPHARM
1420.35
28.1
ALBERTDAVD
406.35
12.1
ALEMBICLTD
81.95
22.51
ALKEM
2422.35
22.91
AMBALALSA
16.95
-84.75
ANUHPHR
225.05
39.41
APLLTD
941.4
18.31
AREYDRG
18
6.82
ARMOURPO
55.25
-93.64
ASTRAZEN
3425.8
118.62
AUROLAB
45.25
6.95
AUROPHARMA
820.75
25.68
BAJAJHCARE
282.75
17.34
123456789
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020